This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents to the Defense Logistics Agency (DLA). The $1,824.64 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 2, 2024, with a final completion date of December 3, 2024. The contract is not designated with a set-aside. Amerisourcebergen maintains significant Indefinite Delivery Contracts (IDCs) with the DLA...
This federal contract award is for the supply of RABAVERT RABIES VACCINE with diluents to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $3,088.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of April 26, 2024 and does not have a set-aside designation....
This federal contract award is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA). The $9,178.15 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 3, 2023, with a completion date of March 6, 2023. The contract is not designated with any set-aside requirements. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS to the U.S. Defense Logistics Agency (DLA). The $3,860.60 firm fixed price contract was awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds several large indefinite delivery contracts (IDCs) with the DLA and other federal agencies. The contract has no set-aside designation and is a delivery order awarded under Amerisourcebergen's...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS, valued at $1,940.37, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of November 13, 2024, and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The firm fixed-price delivery order, valued at $12,017.42, has an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents to the Defense Logistics Agency (DLA). The contract, valued at $27,024.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC...
This federal contract award is for the delivery of RABAVERT rabies vaccine and diluents, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,960.11 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,095.80, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...